Works matching IS 22965270 AND DT 2017 AND VI 40 AND IP 6
Results: 27
Meetings and Conferences.
- Published in:
- 2017
- Publication type:
- Calendar
Obinutuzumab - neuer Standard beim nicht vorbehandelten follikulären Lymphom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 391
- By:
- Publication type:
- Article
Erster Zulassungsantrag zur CAR-T-Zell-Therapie bei Kindern und jungen Erwachsenen mit rezidivierter und refraktärer B-Zell-ALL erhält beschleunigtes FDA-Verfahren.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 390
- Publication type:
- Article
Invasive Pilzinfektionen in der Hämatologie und Onkologie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 390
- By:
- Publication type:
- Article
Cuvitru<sup>®</sup> bietet Patienten mehr Flexibilität im Alltag.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 390
- Publication type:
- Article
Positive CHMP-Empfehlung für Nivolumab zur Behandlung von Patienten mit vorbehandeltem lokal fortgeschrittenem oder metastasiertem Urothelkarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 389
- Publication type:
- Article
Myeloides Engagement von Janssen Oncology.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 389
- Publication type:
- Article
Erypo<sup>®</sup> bei Niedrigrisiko-MDS.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 389
- Publication type:
- Article
Velcade<sup>®</sup> in der Erstlinie: Flexibilität in späteren Therapielinien.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 388
- Publication type:
- Article
Alecensa<sup>®</sup> überzeugt mit beeindruckender systemischer Wirksamkeit und ausgezeichneter Verträglichkeit.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 386
- By:
- Publication type:
- Article
Darzalex<sup>®</sup>: Jetzt auch in der Zweitlinie als Kombinationstherapie zugelassen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 384
- Publication type:
- Article
First-Line-Therapie mit Bevacizumab - Standard beim fortgeschrittenen Ovarialkarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 382
- By:
- Publication type:
- Article
Checkpoint-Blockade jetzt auch bei Kopf-Hals-Tumoren.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 380
- By:
- Publication type:
- Article
Monatsthema im Juni: Hodenkrebs - frühes Erkrankungsalter, gute Heilungschancen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 379
- Publication type:
- Article
Tarnkappen der Tumorzellen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 378
- Publication type:
- Article
JUNGES KREBSPORTAL schafft mit Konsilzugang neues Angebot für medizinische Fachkräfte.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 377
- Publication type:
- Article
Ehrenpreis Geriatrische Onkologie für das Lebenswerk ausgeschrieben.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 376
- By:
- Publication type:
- Article
NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 370, doi. 10.1159/000464465
- By:
- Publication type:
- Article
Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 364, doi. 10.1159/000464410
- By:
- Publication type:
- Article
Malignancy in Solitary Thyroid Nodules: Evaluation of Risk Factors.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 360, doi. 10.1159/000464409
- By:
- Publication type:
- Article
Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 353, doi. 10.1159/000476036
- By:
- Publication type:
- Article
The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 347, doi. 10.1159/000477128
- By:
- Publication type:
- Article
Novel Treatment Options in Head and Neck Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 342, doi. 10.1159/000477254
- By:
- Publication type:
- Article
Human Papillomavirus-Related Head and Neck Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 334, doi. 10.1159/000477252
- By:
- Publication type:
- Article
Epidemiology and Molecular Biology of Head and Neck Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 328, doi. 10.1159/000477127
- By:
- Publication type:
- Article
Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 320, doi. 10.1159/000477097
- By:
- Publication type:
- Article
Head and Neck Cancer - New Insights into a Heterogeneous Disease.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 6, p. 318, doi. 10.1159/000477255
- By:
- Publication type:
- Article